Posted by Michael Wonder on 16 Jan 2023
A new US law aims to reduce drug prices. But first, it might raise them.
14 January 2023 - A new US law meant to blunt drug prices could reduce pharmaceutical-company revenue by about $40 billion over the next decade. But companies hope to soften the blow.
Pharmaceutical companies are grappling with the arrival in the US of sweeping new legislation meant to blunt drug prices. The impact in 2023 may actually be higher drug prices.
